Can Xerese Be Used in a 10-Year-Old?
Yes, Xerese (acyclovir 5%/hydrocortisone 1% cream) can be used in a 10-year-old child for the treatment of recurrent herpes labialis (cold sores). The FDA-approved labeling explicitly states that Xerese is indicated for adults and children 6 years of age and older 1.
FDA-Approved Age Range
The prescribing information is clear and unambiguous:
- Approved for children ≥6 years of age 1
- A 10-year-old falls well within this approved age range
- The dosing regimen is identical to adults: apply topically 5 times per day for 5 days 1
Clinical Evidence in Pediatric Populations
The safety profile in children has been specifically evaluated:
Children 6-11 years old:
- An open-label safety trial enrolled 54 children (mean age 9 years, range 6-11 years) 1
- The safety profile appeared similar to that observed in adults 1
- No dose adjustments are needed for this age group
Adolescents 12-17 years old:
- A separate trial in 134 adolescents demonstrated good tolerability 2
- Only 5 adverse events were reported among 134 subjects, all mild to moderate 2
- 59.5% achieved nonulcerative recurrences (meaning the medication prevented progression to worse lesions) 2
Dosing Instructions for a 10-Year-Old
Apply the same regimen as adults:
- Start treatment at the earliest sign of symptoms (prodrome: tingling, itching, burning) or when lesions first appear 1
- Apply sufficient cream to cover the affected area including the outer margin
- 5 times daily for 5 days 1
- Avoid rubbing the area to prevent aggravation or viral spread 1
Important Safety Considerations
Cutaneous use only:
Common side effects (<1%):
- Drying or flaking of skin
- Burning or tingling after application
- Erythema
- Application site reactions 1
When to seek further medical advice:
- If the cold sore fails to heal within 2 weeks 1
Clinical Context
While the guidelines note that oral antivirals (valacyclovir, famciclovir) are generally superior to topical agents 3, 4, these oral medications have more limited pediatric approval. Valacyclovir and famciclovir are not approved for children under 12 years 4. This makes Xerese a particularly valuable option for the 6-11 year age group, as it provides both antiviral and anti-inflammatory action in a formulation specifically studied and approved for this population 1.
The combination of acyclovir (antiviral) and hydrocortisone (anti-inflammatory) addresses both viral replication and the immune-mediated inflammatory response that causes much of the morbidity in herpes labialis 3, 5.